Stratec SE (ADR)
General ticker "STSEY" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $1.6B (TTM average)
Stratec SE (ADR) does not follow the US Stock Market performance with the rate: -25.8%.
Estimated limits based on current volatility of 0.1%: low 5.10$, high 5.11$
Factors to consider:
- Company pays dividends (annually): last record date 2025-07-01, amount 0.14$ (Y2.75%)
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [4.90$, 15.02$]
- 2025-12-31 to 2026-12-31 estimated range: [4.65$, 13.16$]
Short-term STSEY quotes
Long-term STSEY plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €274.62MM | €261.91MM | €257.62MM |
| Operating Expenses | €234.62MM | €236.48MM | €229.44MM |
| Operating Income | €40.01MM | €25.43MM | €28.18MM |
| Non-Operating Income | €-0.92MM | €-7.21MM | €-6.17MM |
| Interest Expense | €1.90MM | €3.99MM | €5.90MM |
| R&D Expense | €6.87MM | €8.74MM | €11.61MM |
| Income(Loss) | €39.09MM | €18.23MM | €22.01MM |
| Taxes | €9.87MM | €5.16MM | €5.99MM |
| Profit(Loss)* | €29.22MM | €13.07MM | €16.02MM |
| Stockholders Equity | €225.18MM | €233.33MM | €242.53MM |
| Inventory | €117.63MM | €142.62MM | €117.62MM |
| Assets | €397.50MM | €466.58MM | €445.06MM |
| Operating Cash Flow | €10.28MM | €19.43MM | €48.71MM |
| Capital expenditure | €19.02MM | €17.42MM | €18.19MM |
| Investing Cash Flow | €-19.00MM | €-44.16MM | €-15.97MM |
| Financing Cash Flow | €-14.11MM | €35.44MM | €-20.30MM |
| Earnings Per Share** | €0.48 | €0.21 | €0.05 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.